• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
01 Quantum Inc
DEFSEC Technologies Inc. - common stock, no R/S concurrent with offering
Defiance Leveraged Long + Income MSTR ETF
Exascale Labs Holdings Inc. - Class A Common Stock
INNIO N.V. - Ordinary Shares
Integra LifeSciences Holdings Corporation - Common Stock
Invesco S&P MidCap Quality ETF
Itm Power Plc
Iunits S&P/Tsx Capped Energy Index Fund
Lifeward Ltd. - Ordinary Shares
Maui Land & Pineapple Company, Inc. Common Stock
Medical Care Technologies Inc
Mercari Inc
MicroVision, Inc. - Common Stock
Mitsui O.S.K. Lines ADR
Nxt Energy Solutions Inc
Paladin Energy Ltd
Peer To Peer Network
Pirate Gold Corp
Principal Contrarian Value Index ETF
Scorpius Holdings, Inc. Common Stock
Silicon Laboratories, Inc. - Common Stock
Solstice Advanced Materials Inc. - Common Stock
Spectaire Holdings, Inc. - Warrants
Strikepoint Gold Inc
Sunshine Biopharma Inc. - Common stock
Traction Uranium Corp
Trinity Biotech plc - American Depositary Shares
VanEck Industrials TruSector ETF
Vecima Networks Inc
Vencanna Ventures Inc.
ViacomCBS Inc. - Class A Common Stock
Yorkville Acquisition Corp. - Class A Ordinary Share
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TC BioPharm (Holdings) plc - American Depositary Shares (NQ:TCBP)

0.5000 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about TC BioPharm (Holdings) plc - American Depositary Shares

< Previous 1 2 Next >
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) to Be Delisted, Will Move to OTC Markets
March 21, 2025
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Restructures Operations to Enhance Efficiency and Reduce Costs
March 18, 2025
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Signs Letter of Intent to Acquire Ophthalmic Pharma Company
March 05, 2025
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) CEO to Speak at European Life Sciences CEO Forum
February 20, 2025
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Completes Dosing in Phase 2B AML Trial, Reports Positive Early Data
February 13, 2025
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Advances ACHIEVE Trial With Completion of First Cohort B Dosing
February 10, 2025
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces ADS Ratio Change Effective Feb. 10
February 06, 2025
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Advances Preclinical Studies for Bird Flu Treatment with TCB008
January 15, 2025
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) to Present at Sequire Investor Summit 2025
January 13, 2025
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Confirms Continued Nasdaq Trading Under TCBP
January 07, 2025
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Shareholders Approve 25% Stock Dividend
December 30, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Reports Positive Safety Data in ACHIEVE Phase 2b Trial for AML and MDS/AML
December 20, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Special Dividend for Shareholders Amid Ongoing Support
December 18, 2024
Via Investor Brand Network
Topics Regulatory Compliance
News headline image
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) and CareDx Collaborate to Enhance TCB008 Cell Therapy Development for AML
December 11, 2024
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Issues Update on ACHIEVE Clinical Trial
December 05, 2024
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Receives $250,000 Grant to Enhance TCB008 Manufacturing Efficiency
November 12, 2024
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Updates Shareholders on Major Milestones, Expands Clinical Trial Sites and Secures $8M Funding in 2024
October 30, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Collaboration for Monkeypox Treatment Development
October 22, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP), Carnegie Mellon University Partner to Potentially Revolutionize Donor Selection, Matching Processes with AI
October 03, 2024
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Newly Opened London-Based ACHIEVE UK Trial Site Amid ‘Very Positive’ Study Progression
September 25, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Featured at Next Month’s NYC ThinkEquity Conference
September 24, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Completes ACHIEVE Trial Full-Dose Regimen for First Patient
September 23, 2024
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Marks Milestone as First Patient Completes Full Dose in ACHIEVE Trial with No Adverse Events
September 12, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Plans Preclinical Studies for Treatment of Monkey Pox
September 09, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) CEO to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 05, 2024
Via Investor Brand Network
BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Doses Five New Patients in UK ACHIEVE Phase 2b Trial
September 04, 2024
Via Investor Brand Network
News headline image
TC BioPharm CEO, Bryan Kobel, is Featured on The Stock Day Podcast
July 06, 2023
Phoenix, Arizona--(Newsfile Corp. - July 6, 2023) - The Stock Day Podcast welcomed TC BioPharm Holdings, PLC. (NASDAQ: TCBP) ("the... 
Via Newsfile
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
January 19, 2023
EQNX::TICKER_START (NASDAQ:TCBP),(NASDAQ:CRDF),(NASDAQ:CYAD),(NASDAQ:RIGL),(NASDAQ:AZN) EQNX::TICKER_END 
Via FinancialNewsMedia
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
October 24, 2023
EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
January 19, 2023
EQNX::TICKER_START (NASDAQ:TCBP) EQNX::TICKER_END 
Via FinancialNewsMedia
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap